<DOC>
	<DOCNO>NCT02035553</DOCNO>
	<brief_summary>This study evaluate safety efficacy pimavanserin 40 mg compare placebo patient Alzheimer 's disease psychosis .</brief_summary>
	<brief_title>A Study Safety Efficacy Pimavanserin Patients With Alzheimer 's Disease Psychosis</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Mental Disorders</mesh_term>
	<mesh_term>Pimavanserin</mesh_term>
	<criteria>Patient must 50 year age old NINCDSADRDA define possible probable AD Patient must psychotic symptom develop diagnosis AD establish . These symptom must include visual and/or auditory hallucination , and/or delusion Patient must nurse home resident ≥ 2 week prior Screening ≥ 4 week prior randomization , bedridden expect remain facility throughout study Patient must actively experience verbally communicate psychotic symptom month prior Screening visit weekly previous 2 week prior Baseline If patient acetylcholinesterase inhibitor ( AChEI ) therapy and/or memantine , must stable dos 3 month prior Baseline visit study Patient willing able provide inform consent . If subject unable provide write consent due severity dementia , consent must give legally authorize representative Patient history significant psychotic disorder prior concomitantly diagnosis Alzheimer 's disease include , limited , schizophrenia bipolar disorder Patient unable communicate verbally Patient current evidence serious and/or unstable cardiovascular , respiratory , gastrointestinal , renal , hematologic medical disorder , include cancer malignancy , would affect patient 's ability participate study Patient myocardial infarction last six month Patient moderate severe congestive heart failure Patient surgery plan screening , treatment , followup period could interfere participation study per protocol assessment Patients evaluate screening ensure criterion study participation met . These evaluation include specific measure psychosis severity , delirium , dementia , cardiovascular condition , pregnancy status . Patients may exclude study base assessment ( specifically determine baseline health psychiatric condition meet protocolspecified entry criterion ) .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>